Press Room

Twelve finalists have been selected to pitch their pediatric medical device innovation during the National Capital Consortium for Pediatric Device Innovation competition at the Fifth Annual Pediatric Device Innovation Symposium. Hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System, the Symposium will be held on Sunday, Sept. 24, 2017 in San Jose, Calif.

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovationhave completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

The National Capital Consortium for Pediatric Device Innovation is extending the deadline for the “Make Your Medical Device Pitch for Kids!” competition to Thursday, Aug. 24, 2017 at midnight PDT.

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is now accepting proposals for medical devices that address a significant yet unmet pediatric need. This year, up to six innovations will be awarded up to $50,000 each during the pediatric medical device pitch competition on Sunday September 24, 2017.

Children’s National's proprietary robotic surgical technology Smart Tissue Autonomous Robot (STAR) has been named one of the top ten finalists in the 2017 NASA iTech call for ideas challenge.

Facial analysis software can assist clinicians in making accurate diagnosis of 22q1.2 deletion syndrome (also called DiGeorge syndrome), according to an international study published in the April 2017 issue of the American Journal of Medical Genetics.

The study, led by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, used an objective digital facial analysis technology developed by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System to identify the most relevant facial features characteristic in Down syndrome in diverse populations from 12 countries. This NHGRI study is the first to compare and contrast Down syndrome across diverse populations.

Children’s National and Celsion announce clinical study to treat recurrent childhood tumors using MR-HIFU targeting to apply heat-activated chemotherapy drug

The volume of an optic nerve glioma (OPG) is directly correlated with the likelihood of vision loss in children with neurofibromatosis type 1 (NF1), according to a study published in the November 2016, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is the first to use quantitative imaging technology to accurately assess the total volume of individual OPGs in NF1.

His Highness Sheikh Abdullah bin Zayed Al Nahyan, UAE Minister of Foreign Affairs and International Cooperation, met with a delegation from Children’s during an event at Tawam Hospital in Al Ain, UAE.